Hyperostosis with hyperphosphatemia and tumoral calcinosis: a case report.
The combination of hyperostosis and hyperphosphatemia is very rare. In this case report, we present a boy with a combination of diffuse hyperostosis and hyperphosphatemia. We evaluated most possible known causes of hyperphosphatemia and hyperostosis. He had normal renal function and serum parathormone level. Concerning some few similar cases, most of them from Middle Eastern countries, we present this combination (diffuse hyperostosis and hyperphosphatemia) as a new syndrome to be discussed in pediatric textbooks.
Otukesh
Hasan
H
Aliasghar Children's Hospital, Tehran, Iran. hasanotukesh@yahoo.com
Hoseini
Rozita
R
Chalian
Hamid
H
Chalian
Majid
M
Safarzadeh
Amir Ebrahim
AE
Shakiba
Marjan
M
Poorian
Ali
A
D000086:Acetazolamide / Q000008:administration & dosage / Q000627:therapeutic use; D002114:Calcinosis / Q000000981:diagnostic imaging / Q000378:metabolism*; D002118:Calcium / Q000097:blood / Q000378:metabolism*; D002119:Calcium Carbonate / Q000008:administration & dosage / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D002614:Chelating Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D006801:Humans; D015576:Hyperostosis / Q000378:metabolism*; D008297:Male; D010026:Osteosclerosis / Q000175:diagnosis / Q000209:etiology; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood*; D011073:Polyamines / Q000008:administration & dosage / Q000627:therapeutic use; D011859:Radiography; D000069603:Sevelamer; D016896:Treatment Outcome
D002257:Carbonic Anhydrase Inhibitors; D002614:Chelating Agents; D010281:Parathyroid Hormone; D010710:Phosphates; D011073:Polyamines; D000069603:Sevelamer; D002119:Calcium Carbonate; D000086:Acetazolamide; D002118:Calcium